Dr. Paul O’Byrne, principal investigator for AllerGen’s Clinical Investigator Collaborative Legacy Project, Professor and Chair of Medicine at McMaster University, and Director of the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare, is one of five faculty members just …
Head of AllerGen’s CIC honoured by McMaster University Read More »
AllerGen partner organization the Asthma Society of Canada is holding the event “Clearing the Air: Asthma and Allergies in a Time of Climate Change” on May 4 and 5, 2015, in Toronto, ON, to coincide with World Asthma Day. Motivated …
AllerGen Scientific Director Dr. Judah Denburg will speak on the topic of “In situ hemopoiesis in allergic inflammation and disease: from serendipity to prediction” as part of the Biomedical Research Centre Seminar Series of The University of British Columbia (UBC). …
Scientific Director speaks at UBC Biomedical Research Centre Read More »
AllerGen investigators Dr. Catherine Laprise and Dr. Christopher Carlsten have each been awarded a Canada Research Chair for their outstanding work in the field of asthma and allergies. Dr. Laprise, a professor in the Fundamentals Sciences Department at the Université …
New Canada Research Chair awards for AllerGen investigators Read More »
AllerGen researchers have published a new review in Mucosal Immunology (a high-impact journal of the Nature group) that outlines the contributions of blood cell production by the bone marrow and “in situ” blood cell development that occurs at a local site …
Role of stem cells in development of allergies and asthma Read More »
Researchers from AllerGen’s Canadian Healthy Infant Longitudinal Development (CHILD) Study have deeply assessed indoor and outdoor environmental exposures for 3,217 Canadian babies—an unprecedented accomplishment for any birth cohort. The CHILD Study is examining how a child’s environment during pregnancy and …
CHILD Study assesses environmental exposures for over 3,200 babies Read More »
Dr. Bruce Mazer has been named the Deputy Executive Director/Deputy Chief Scientific Officer of the Research Institute of the McGill University Health Centre (RI-MUHC) and Head of Child Health Research at the Montreal Children’s Hospital (MCH) of the McGill University …
In his new book “The Personalized Medicine Revolution: How Diagnosing and Treating Disease Are About to Change Forever” (Greystone Books), Dr. Pieter Cullis explains how healthcare tailored to each individual’s unique molecular makeup will cut costs, reduce adverse drug reactions, and …
Dr. Bruce Mazer explains how the Learning Early about Peanut Allergy (LEAP) trial is changing our approach to peanut allergy. The study found that infants (between 4−11 months) who consumed at least 6 grams of peanut per week were significantly …
The annual incidence of recurrent anaphylaxis in children is 29%, according to new findings from AllerGen’s Cross-Canada Anaphylaxis REgistry (C-CARE) project. Dr. Andrew O’Keefe, an allergist from St. John’s, Newfoundland, presented the results at the American Academy of Allergy, Asthma …
A new publication using CHILD Study data reports new findings on the relationship between changes in infants’ intestinal bacteria and allergic sensitization to milk, egg or peanut at 12 months of age. The paper “Infant gut microbiota and food sensitization: …
AllerGen investigator Dr. Meghan Azad was pleased to join a conversation on maternal, newborn and child health (MNCH) with Prime Minister Stephen Harper and billionaire philanthropist Bill Gates in Ottawa, ON, on Wednesday, February 25. The moderated discussion focused on …